Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation

International Journal of Molecular Medicine

Volumn 34, Issue 3, 2014, Pages 695-704

  Li, Xiuying ^a   Bai, Jinping ^a   Ji, Xiaofeng ^a   Li, Ronggui ^a   Xuan, Yali ^b   Wang, Yimin ^a,b  

^a JILIN UNIVERSITY   (China)

^b Jilin Zhongke Bio engineering Co Ltd   (China)

Author keywords

Bone marrow; Immunomodulation; Lymphocytes; Mesenchymal stem cels; Wharton's Jelly

Indexed keywords

JAGGED1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; PHYTOHEMAGGLUTININ; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; BIOLOGICAL MARKER;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL THERAPY; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION; GROWTH RATE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NORMAL HUMAN; PLACENTA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UMBILICAL CORD; WHARTON JELLY; ADIPOCYTE; ADOLESCENT; BONE MARROW CELL; CELL COUNT; CYTOLOGY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PREGNANCY; YOUNG ADULT;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OSTEOGENESIS; PLACENTA; PREGNANCY; T-LYMPHOCYTES; WHARTON JELLY; YOUNG ADULT;

EID: 84904959350     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1821     Document Type: Article

References (52)

1. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF and Keiliss-Borok IV: Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17: 331-340, 1974.
2. Caplan AI: Mesenchymal stem cells. J Orthop Res 9: 641-650, 1991.
3. Kopen GC, Prockop DJ and Phinney DG: Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 96: 10711-10716, 1999. (Pubitemid 29442209)
4. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999. (Pubitemid 29282067)
5. Beltrami AP, Cesselli D, Bergamin N, et al: Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 110: 3438-3446, 2007. (Pubitemid 350106340)
6. Fan CG, Zhang QJ and Zhou JR: Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev 7: 195-207, 2011.
7. Mosna F, Sensebe L and Krampera M: Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem Cells Dev 19: 1449-1470, 2010.
8. Friedenstein AJ, Petrakova KV, Kurolesova AI and Frolova GP: Heterotopic of bone marrow. Analysis of precursor cells for osteo genic and hematopoietic tissues. Transplantation 6: 230-247, 1968.
9. Tondreau T, Meuleman N, Delforge A, et al: Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23: 1105-1112, 2005. (Pubitemid 41377726)
10. Zuk PA, Zhu M, Mizuno H, et al: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228, 2001. (Pubitemid 32295155)
11. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I and Fisk NM: Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98: 2396-2402, 2001.
12. Keating A: Mesenchymal stromal cells. Curr Opin Hematol 13: 419-425, 2006.
13. Friedenstein AJ, Chailakhjan RK and Lalykina KS: The develop ment of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3: 393-403, 1970.
14. Friedenstein AJ, Gorskaja JF and Kulagina NN: Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4: 267-274, 1976.
15. Grassel S, Stockl S and Jenei-Lanzl Z: Isolation, culture, and osteogenic/chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Methods Mol Biol 879: 203-267, 2012.
16. Eslaminejad MB, Mirzadeh H, Mohamadi Y and Nickmahzar A: Bone differentiation of marrow-derived mesenchymal stem cells using beta-tricalcium phosphate-alginate-gelatin hybrid scaffolds. J Tissue Eng Regen Med 1: 417-424, 2007.
17. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L and Verfaillie CM: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 2615-2625, 2001.
18. Tomic S, Djokic J, Vasilijic S, et al: Immunomodulatory prop erties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists. Stem Cells Dev 20: 695-708, 2011.
19. Toubai T, Paczesny S, Shono Y, et al: Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation. Curr Stem Cell Res Ther 4: 252-259, 2009.
20. Tse WT, Pendleton JD, Beyer WM, Egalka MC and Guinan EC: Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75: 389-397, 2003. (Pubitemid 36222968)
21. Ramasamy R, Tong CK, Seow HF, Vidyadaran S and Dazzi F: The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 251: 131-136, 2008.
22. Che N, Li X, Zhou S, et al: Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation. Cell Immunol 274: 46-53, 2012.
23. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC and Moretta L: Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107: 1484-1490, 2006. (Pubitemid 43242385)
24. Deuse T, Stubbendorff M, Tang-Quan K, et al: Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 20: 655-667, 2011.
25. Najar M, Raicevic G, Id Boufker H, et al: Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Exp Hematol 38: 922-932, 2010.
26. De Bruyn C, Najar M, Raicevic G, et al: A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev 20: 547-557, 2011.
27. Battula VL, Bareiss PM, Treml S, et al: Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75: 279-291, 2007. (Pubitemid 46434949)
28. Livak KJ and Schmittgen TD: Analysis of relative gene expres sion data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
29. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL and Fink DJ: Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 16: 406-413, 1998. (Pubitemid 28427689)
30. Wakitani S, Saito T and Caplan AI: Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18: 1417-1426, 1995.
31. Parker AM and Katz AJ: Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opin Biol Ther 6: 567-578, 2006. (Pubitemid 43837184)
32. Kobayashi K, Kubota T and Aso T: Study on myofibroblast differentiation in the stromal cells of Wharton's jelly: expression and localization of alpha-smooth muscle actin. Early Hum Dev 51: 223-233, 1998. (Pubitemid 28331844)
33. Wulf GG, Viereck V, Hemmerlein B, et al: Mesengenic progenitor cells derived from human placenta. Tissue Eng 10: 1136-1147, 2004. (Pubitemid 39223792)
34. Chen MY, Lie PC, Li ZL and Wei X: Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp Hematol 37: 629- 640, 2009.
35. Baksh D, Yao R and Tuan RS: Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25: 1384-1392, 2007. (Pubitemid 47106005)
36. Raynaud CM, Maleki M, Lis R, et al: Comprehensive charac terization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation. Stem Cells Int 2012: 658356, 2012.
37. Zhu SF, Zhong ZN, Fu XF, et al: Comparison of cell proliferation, apoptosis, cellular morphology and ultrastructure between human umbilical cord and placenta-derived mesenchymal stem cells. Neurosci Lett 541: 77-82, 2013.
38. Stenderup K, Justesen J, Clausen C and Kassem M: Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-926, 2003. (Pubitemid 37543568)
39. Post S, Abdallah BM, Bentzon JF and Kassem M: Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone 43: 32-39, 2008.
40. Larsen KH, Frederiksen CM, Burns JS, Abdallah BM and Kassem M: Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. J Bone Miner Res 25: 796- 808, 2010.
41. De Ugarte DA, Morizono K, Elbarbary A, et al: Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174: 101-109, 2003. (Pubitemid 36819010)
42. Lorenz K, Sicker M, Schmelzer E, et al: Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol 17: 925-932, 2008.
43. Kern S, Eichler H, Stoeve J, Kluter H and Bieback K: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301, 2006. (Pubitemid 44464698)
44. Zhang X, Hirai M, Cantero S, et al: Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem 112: 1206-1218, 2011.
45. Dazzi F and Krampera M: Mesenchymal stem cells and auto immune diseases. Best Pract Res Clin Haematol 24: 49-57, 2011.
46. Kebriaei P and Robinson S: Treatment of graft-versus-host-disease with mesenchymal stromal cells. Cytotherapy 13: 262-268, 2011.
47. Kode JA, Mukherjee S, Joglekar MV and Hardikar AA: Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11: 377-391, 2009.
48. Krampera M, Glennie S, Dyson J, et al: Bone marrow mesen chymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101: 3722-3729, 2003. (Pubitemid 36857965)
49. Polchert D, Sobinsky J, Douglas G, et al: IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 38: 1745-1755, 2008.
50. Rubinstein P, Rosenfield RE, Adamson JW and Stevens CE: Stored placental blood for unrelated bone marrow reconstitution. Blood 81: 1679-1690, 1993. (Pubitemid 23101579)
51. Augello A, Tasso R, Negrini SM, et al: Bone marrow mesen chymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 35: 1482-1490, 2005. (Pubitemid 40691430)
52. Yang SH, Park MJ, Yoon IH, et al: Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Exp Mol Med 41: 315-324, 2009.